Source: Virtual Congress 2020 – Screening and early lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
F. Bintein (Paris, France), A. Yannoustsos (Paris, France), G. Chatellier (Paris, France), M. Fontaine (Paris, France), D. Damotte (Paris, France), P. Paterlini-Bréchot (Paris, France), G. Meyer (Paris, France), V. Duchatelle (Paris, France), V. Marini (Paris, France), K. Schwering (Paris, France), C. Labrousse (Paris, France), H. Beaussier (Paris, France), M. Zins (Paris, France), S. Salmeron (Paris, France), J. Lajonchère (Paris, France), P. Priollet (Paris, France), J. Emmerich (Paris, France), J. Trédaniel (Paris, France). Prevalence of lung cancer in patients with atherosclerotic peripheral arterial disease:meta-analysis of literature data. 1612

Member's Comments

No comment yet.

Related content which might interest you: Increased risk of peripheral arterial disease in individuals with COPD Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017 Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021 Venous thromboembolic disease in patients with small cell lung cancer: incidence and clinicopathological risk factors Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Comparison of risk prediction scores for venous thromboembolism in lung cancer patients: a retrospective cohort study Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Hemodynamics and response to therapy of pulmonary hypertension in patients with interstitial lung disease: Preliminary results of the "HYPID" prospective study Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment Year: 2012 Interpreting risk reduction in clinical trials for pulmonary arterial hypertension Source: Eur Respir Rev, 27 (148) 180020; 10.1183/16000617.0020-2018 Year: 2018 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 COPD is associated with an increased risk of peripheral artery disease and mortality Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018 Year: 2018 Cross-sectional study on therapeutic adherence and disease knowledge of patients affected by chronic obstructive pulmonary disease. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Audit of disease targeted therapies in adult patients with pulmonary arterial hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease in the French PAH registry Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2011; 38: 1261-1277 Year: 2011 Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 549-555 Year: 2010 Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Pulmonary hypertension in COPD patients: a systematic review and meta-analysis Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Pulmonary arterial hypertension related with congenital heart disease (PAH r-CHD): a retrospective study of 21 patients Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Prevalence of undiagnosed COPD: systematic review and meta-analysis Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019 Year: 2020 Evaluation of cancer-associated thrombosis risk in patients with lung adenocarcinoma using the COMPASS-CAT risk assessment model Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021